Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Michel

Gilliet

,

MD

Professor and Chair, Department of Dermatology
University of Lausanne
Lausanne
,
Switzerland
Councilor Since: November 1, 2012
IPC Councilor
Request an Update
Dr. Michel Gilliet is the Head of the Dermatology Department at the University Hospital CHUV in Lausanne, Switzerland. He completed his dermatology training at the University of Zurich and received research training in immunology at the DNAX Research Institute in Palo Alto, California. In 2004, Dr. Gilliet was recruited by MD Anderson Cancer Center in Houston, Texas, where he held clinical appointments in Dermatology and basic and translational science appointments in Melanoma Oncology and Immunology.

In 2010, Dr. Gilliet returned to Switzerland as a Full Professor and Head of the Dermatology Department in Lausanne. His research primarily focuses on immune responses in inflammatory skin diseases. His laboratory has notably uncovered mechanisms by which dendritic cells initiate and sustain skin inflammation by sensing DNA in complex with antimicrobial peptides. These groundbreaking studies have led to a paradigm shift in understanding how inflammation is regulated in injured skin and diseases such as psoriasis and lupus erythematosus. More recently, his lab has expanded its research to include the application of molecular omics technologies in clinical dermatology practice, providing a new framework for diagnosing and treating skin diseases.

Dr. Gilliet’s research has led to over 140 publications and garnered 30,000 citations, with his work regularly featured in prestigious journals such as Nature, Science, Nature Immunology, Nature Medicine, and Nature Communications.

Dr. Gilliet has served as President of the European Society for Dermatological Research (ESDR) and is currently President of the Skin Science Foundation. He also serves on the Board of the European Academy of Dermatology and Venereology (EADV), where he chairs the Scientific Program. In recognition of his contributions to medical research, he received the Cloetta Prize, Switzerland’s most prestigious medical research award, in 2016. In 2023, he was elected to the National Academy of Sciences in Germany.
Last Updated:
07/10/2025

Languages Spoken

English, German
Recent publications

Featured

Blog

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment…

Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…

Read More

Blog

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic…

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…

Read More

Blog

2025 IPC Think Tank Congress Report: Psoriasis, Metabolic Health, and GLP-1 Therapies.

The 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…

Read More

Blog

Focus on Psoriasis: Highlights from the 2025 ESDR Annual Meeting.

The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…

Read More

Blog

Focus on Psoriasis: Highlights from the 2025 EADV Congress.

At the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and…

Read More

PDF

A Report from the 54th Annual Meeting of the European Society for Dermatological Research (ESDR).

The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…

View Report

Page

Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.

Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…

View Report

Blog

Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.

Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…

Read More

PDF

Focus on Psoriasis: Highlights from the 2025 Society for Investigative Dermatology (SID) Annual Meeting.

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

View Report

Blog

Focus on Psoriasis: Highlights from the 2025 Society for Investigative Dermatology (SID) Annual Meeting.

IPC’s 2025 SID Congress Report highlights the most impactful psoriasis sessions, covering novel cell-biology…

Read More

Blog

Highlights from the 2025 American Academy of Dermatology (AAD) Annual Meeting: Psoriasis Comorbidities, New Treatments,…

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

Read More

Blog

Focus on Psoriasis: A Report from the Psoriasis: From Gene to Clinic 10th International Congress.

The Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment…

Read More

Blog

Focus on Psoriasis: A Report from the 53rd Annual European Society for Dermatological Research (ESDR) Meeting.

This report from the 53rd Annual ESDR Meeting in Lisbon covers key presentations on psoriasis, including updates from…

Read More

Event

IPC & IEC Symposium: From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis and Eczema.

EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH ANNUAL MEETING (ESDR) | LISBON, PORTUGAL Program chairs: Johann…

September 4, 2024
Learn More or Register

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026